Qingdao Vland Biotech INC. (SHSE: 603739)
Health Care · Biotechnology · CN
CN¥12.29
-2.46% today · -19.3% 1Y
Qingdao Vland Biotech INC. (SHSE: 603739) operates in the Biotechnology industry within the Health Care sector. The company is valued at $462.59M and employs 1,522 people.
Over the last twelve months the share price has lost 19.3%, trading between 10.68 and 18.41.
Tweenvest scores Qingdao Vland Biotech INC. across four factors: quality 71/100, value 51/100, growth 24/100, dividend 46/100. Its strongest factor is quality.
603739 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $462.59M
- Revenue (TTM)
- $203.12M
- P/E
- 39.86
- EPS
- 0.31
- Dividend yield
- 0.81%
- Beta (5Y)
- 0.37
- 52-week high
- CN¥18.41
- 52-week low
- CN¥10.68
- Avg volume (3M)
- —
- Shares outstanding
- 253.03M
- Employees
- 1,522
- Next earnings
- —
About Qingdao Vland Biotech INC.
Qingdao Vland Biotech Inc. specializes in the research, development, and production of enzymes, probiotics, animal vaccines, and veterinary health products. Its extensive product range features enzymes for animal feed, industrial uses, and food processing, along with various probiotics, such as aquaculture premixes, general health supplements, and both animal and plant-specific formulations. The company also provides a comprehensive array of animal vaccines and biological solutions, including both live and inactivated vaccines for poultry and swine, in addition to antibodies. Its offerings extend to poultry pharmaceuticals, covering antiparasitic, antiviral, and nutritional medications, alongside disinfectants. Furthermore, it supplies traditional Chinese veterinary remedies designed for aquatic species, poultry, and livestock, including laying hens. Vland Biotech's diverse clientele operates across numerous sectors, such as agriculture, animal husbandry, textile manufacturing, papermaking, household cleaning and detergents, food production, biofuel development, and environmental protection. This entity, established in 2005 and headquartered in Qingdao, China, operates as a subsidiary of Qingdao Kangdien Industrial Co., Ltd.
- ISIN
- CNE100003GX8
- Founded
- 2005
- Listed since
- Jan 29, 2019
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.